4 recruiting, 2 not yet recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Hypoxic Ischemic Encephalopathy (HIE): new trials by email Literature Review of Hypoxic Ischemic Encephalopathy (HIE) trials Research Report on Hypoxic Ischemic Encephalopathy (HIE)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caffeine for Hypoxic Ischemic Encephalopathy Caffeine citrate oral solution, Oral placebo solution - Hypoxic Ischemic Encephalopathy (HIE) | Phase 3 | Recruiting | NICHD Global Network for Women's and Children's Health | 830 | 2026-04-08 | 2026-06-24 |
| Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD) | Recruiting | Healing Hope International | 100 | 2026-03-01 | 2026-03-25 | |
| Severity of Hypoxic Ischemic Encephalopathy and Neurological Pupil Index in Neonates Automated Pupillometer - Hypoxic Ischemic Encephalopathy (HIE) | Not yet recruiting | University of Calgary | 25 | 2025-08-01 | 2025-06-17 | |
| The HIEnome Study: Genome Sequencing for Perinatal HIE Genome sequencing - Hypoxic Ischemic Encephalopathy of Newborn, Hypoxic Ischemic Encephalopathy | Not applicable | Recruiting | Baylor College of Medicine | 25 | 2025-05-15 | 2026-10-01 |
| Neonates With Hypoxic Ischemic Encephalopathy (HIE) Hypoxic Ischemic Encephalopathy (HIE) | Not yet recruiting | Assiut University | 72 | 2024-12-01 | 2024-11-19 | |
| Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS) Cardiac Arrest, Inflammation | Recruiting | MaineHealth | 400 | 2016-01-01 | 2025-07-18 |
Hypoxia-Ischemia, Brain (6) · Autism Spectrum Disorder (1) · Brain Injuries, Traumatic (1) · Cerebral Palsy (1) · Chromosome Aberrations (1) · Developmental Disabilities (1) · DiGeorge Syndrome (1) · Down Syndrome (1) · Emotional Regulation (1) · Fibromatosis, Gingival, 2 (1) · Fragile X Syndrome (1) · Genetic Diseases, Inborn (1) · Heart Arrest (1) · Inflammation (1) · Neurodevelopmental Disorders (1)
Brain Diseases (6) · Brain Ischemia (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Hypoxia (6) · Hypoxia, Brain (6) · Nervous System Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Signs and Symptoms, Respiratory (6) · Vascular Diseases (6) · Heart Diseases (2) · Neurologic Manifestations (2) · Pathologic Processes (2)
caffeine citrate (1)
Assiut University (1) · Baylor College of Medicine (1) · Healing Hope International (1) · MaineHealth (1) · NICHD Global Network for Women's and Children's Health (1) · University of Calgary (1)
United States (3) · Bangladesh (1) · Canada (1) · Democratic Republic of the Congo (1) · Guatemala (1) · India (1) · Pakistan (1) · Zambia (1)
David B Seder, MD (1) · Denise C Babineau, PhD (1) · Dr. Tina Casoglos-Adamopoulos, OT, OTD, BCP (1) · Elizabeth M McClure, PhD (1) · Khorshid Mohammad, MD, MSc, FRCP, FRCPC (1) · Melissa Bauserman, MD, MPH (1) · Sergey Ryzhov, MD, PhD (1)
PMID 16631096, PMID 20381069, PMID 22926849, PMID 26409031, PMID 27072310, PMID 29534018, PMID 30478620, PMID 31069659, PMID 31237169, PMID 31450231, PMID 32096118, PMID 32166235, PMID 32216772, PMID 35445823, PMID 35773500, PMID 37927706, PMID 38325139
P20GM139745 (1)